Form 4: Bicycle Therapeutics CEO Kevin Lee Sells Shares to Cover Tax Obligations

Bicycle Therapeutics CEO Kevin Lee sold 3,194 ordinary shares to cover statutory tax withholding obligations related to the vesting and settlement of Restricted Stock Units (RSUs).

Summary

• On July 3, 2024, Kevin Lee, CEO of Bicycle Therapeutics PLC, sold 3,194 ordinary shares of the company.
• The sale was executed to cover statutory tax withholding obligations associated with the vesting and settlement of RSUs.
• The shares were sold at a weighted average price of $19.64, with individual transactions ranging from $19.63 to $19.69.
• Following the transaction, Lee still beneficially owns 384,076 ordinary shares of Bicycle Therapeutics PLC.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the transaction is a routine sale to cover tax obligations and doesn't reflect a change in the executive's confidence in the company.

Industry Context

Sales of shares to cover tax obligations upon vesting of restricted stock units are a common practice among corporate executives and do not necessarily indicate a negative outlook on the company's future.

Stakeholder Impact

• The sale of shares may have a minimal impact on shareholders due to the small volume of shares sold.
• The transaction ensures the executive remains compliant with tax obligations.

Key Dates